University of Tennessee Medical Center Cancer Institute — Knoxville, Tennessee

University of Tennessee Medical Center Cancer Institute is a clinical research site located in Knoxville, Tennessee, United States 37920.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Tennessee Medical Center Cancer Institute has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: Pancreatic Cancer, Melanoma, PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC.

Sponsors: XBiotech, Inc., Pfizer, Genmab.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Tennessee Medical Center Cancer Institute?

University of Tennessee Medical Center Cancer Institute has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Tennessee Medical Center Cancer Institute conducted?

University of Tennessee Medical Center Cancer Institute has 6 clinical trials on record, with 2 currently active. Their work covers Pancreatic Cancer, Melanoma, PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC.

Is University of Tennessee Medical Center Cancer Institute accredited by Crixeo Health?

Yes — University of Tennessee Medical Center Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Tennessee Medical Center Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.